As on Wednesday, Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) started slowly as it slid -3.68% to $0.34, before settling in for the price of $0.35 at the close. Taking a more long-term approach, CYCC posted a 52-week range of $0.25-$39.84.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its Annual Earning per share during the time was 57.31%. This publicly-traded company’s shares outstanding now amounts to $22.27 million, simultaneously with a float of $22.27 million. The organization now has a market capitalization sitting at $7.52 million. At the time of writing, stock’s 50-day Moving Average stood at $2.5914, while the 200-day Moving Average is $7.0656.
Cyclacel Pharmaceuticals Inc (CYCC) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Cyclacel Pharmaceuticals Inc’s current insider ownership accounts for 0.00%, in contrast to 0.46% institutional ownership. According to the most recent insider trade that took place on Feb 26 ’25, this organization’s Interim CEO sold 194,628,820 shares at the rate of 0.03, making the entire transaction reach 5,507,996 in total value, affecting insider ownership by 0.
Cyclacel Pharmaceuticals Inc (CYCC) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) Trading Performance Indicators
Let’s observe the current performance indicators for Cyclacel Pharmaceuticals Inc (CYCC). It’s Quick Ratio in the last reported quarter now stands at 5.60. The Stock has managed to achieve an average true range (ATR) of 0.32. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 752.00.
In the same vein, CYCC’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -48.93.
Technical Analysis of Cyclacel Pharmaceuticals Inc (CYCC)
Through scrutinizing the latest numbers posted by the [Cyclacel Pharmaceuticals Inc, CYCC], it can be observed that its last 5-days Average volume of 6.58 million was better the volume of 0.79 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 11.74% While, its Average True Range was 0.2245.
Raw Stochastic average of Cyclacel Pharmaceuticals Inc (CYCC) in the period of the previous 100 days is set at 1.35%, which indicates a major fall in contrast to 5.58% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 416.78% that was higher than 202.54% volatility it exhibited in the past 100-days period.
